American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$355M |
| 2 |
Gilead Sciences
GILD
|
+$211M |
| 3 |
CMA
Comerica
CMA
|
+$192M |
| 4 |
Dow Inc
DOW
|
+$167M |
| 5 |
Zebra Technologies
ZBRA
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$297M |
| 2 |
Boeing
BA
|
+$271M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$270M |
| 4 |
Mondelez International
MDLZ
|
+$226M |
| 5 |
JPMorgan Chase
JPM
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.82% |
| 2 | Healthcare | 15.61% |
| 3 | Technology | 15.09% |
| 4 | Consumer Discretionary | 11.61% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
901
Kyntra Bio
KYNB
$28.5M
| $3.67M | ﹤0.01% |
3,245
-8
| -0.2% | -$8.76K |
|
902
Palomar
PLMR
$3.37B
| $3.6M | ﹤0.01% |
+149,886
| New | +$3.3M |
|
903
Petrobras Class A
PBR.A
$104B
| $3.59M | ﹤0.01% |
252,861
-3,800
| -1% | -$52.3K |
|
|
PR
904
Permian Resources
PR
$17.7B
| $3.58M | ﹤0.01% |
471,856
+157,850
| +50% | +$1.4M |
|
905
Voyager Therapeutics
VYGR
$198M
| $3.57M | ﹤0.01% |
131,131
-60,532
| -32% | -$1.39M |
|
906
TD Synnex
SNX
$20.4B
| $3.56M | ﹤0.01% |
+72,352
| New | +$3.59M |
|
907
Toronto Dominion Bank
TD
$203B
| $3.53M | ﹤0.01% |
60,460
+13,520
| +29% | +$760K |
|
|
PTLA
908
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.53M | ﹤0.01% |
129,976
+39,429
| +44% | +$1.24M |
|
909
Schwab International Small-Cap Equity ETF
SCHC
$5.69B
| $3.5M | ﹤0.01% |
+107,333
| New | +$3.48M |
|
910
Hawaiian Electric Industries
HE
$2.04B
| $3.45M | ﹤0.01% |
79,283
+67,658
| +582% | +$2.84M |
|
|
ONDK
911
DELISTED
On Deck Capital, Inc.
ONDK
| $3.45M | ﹤0.01% |
831,366
-138,330
| -14% | -$653K |
|
|
MDCO
912
DELISTED
Medicines Co
MDCO
| $3.45M | ﹤0.01% |
94,585
-275
| -0.3% | -$8.98K |
|
913
Graham Corp
GHM
$1.3B
| $3.44M | ﹤0.01% |
170,278
+92,135
| +118% | +$1.89M |
|
914
Snap
SNAP
$8.96B
| $3.39M | ﹤0.01% |
237,106
+201,479
| +566% | +$2.46M |
|
|
MEET
915
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $3.36M | ﹤0.01% |
964,699
+670,659
| +228% | +$2.98M |
|
916
Consolidated Edison
ED
$40.1B
| $3.35M | ﹤0.01% |
38,158
-1,064
| -3% | -$91.7K |
|
|
AIMT
917
DELISTED
Aimmune Therapeutics
AIMT
| $3.34M | ﹤0.01% |
160,431
+26,201
| +20% | +$539K |
|
918
Spok Holdings
SPOK
$230M
| $3.31M | ﹤0.01% |
219,793
-56,886
| -21% | -$844K |
|
|
GLDD
919
DELISTED
Great Lakes Dredge & Dock
GLDD
| $3.28M | ﹤0.01% |
297,038
+74,313
| +33% | +$767K |
|
920
MDU Resources
MDU
$4.27B
| $3.27M | ﹤0.01% |
333,656
+85,553
| +34% | +$833K |
|
921
HUB Group
HUBG
$2.55B
| $3.24M | ﹤0.01% |
154,502
+49,326
| +47% | +$1.04M |
|
|
GBT
922
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.23M | ﹤0.01% |
61,472
+14,293
| +30% | +$821K |
|
923
Insperity
NSP
$2.05B
| $3.23M | ﹤0.01% |
26,455
-4,354
| -14% | -$525K |
|
924
Best Buy
BBY
$18B
| $3.23M | ﹤0.01% |
46,255
+459
| +1% | +$32K |
|
|
AERI
925
DELISTED
Aerie Pharmaceuticals
AERI
| $3.21M | ﹤0.01% |
108,735
+24,720
| +29% | +$952K |
|
Similar funds
American Century Companies's Q2 2019 Portfolio in Review
As of Q2 2019, American Century Companies held 1,423 positions worth $100B, up 1.8% from $98.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q2 2019 filing shows 209 new, 531 increased, 497 reduced and 163 closed positions. Its largest new stake was Dow Inc: 3,155,090 shares worth $156M. The largest sale was Apple, an estimated $297M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
- American Century Companies's largest Q2 2019 buy was Dow Inc: 3,155,090 shares worth $156M.
- American Century Companies added most to iShares Russell 1000 Value ETF in Q2 2019, an estimated $355M increase.
- American Century Companies's biggest Q2 2019 reduction was Apple, cutting an estimated $297M.
- American Century Companies fully exited WABCO HOLDINGS INC. in Q2 2019, selling an estimated $149M.
- American Century Companies's ten largest holdings make up 18% of its $100B portfolio in Q2 2019.
- American Century Companies opened 209 new positions and closed 163 in Q2 2019.
- American Century Companies's portfolio value rose 1.8% quarter-over-quarter to $100B.
Based on American Century Companies's 13F filing for Q2 2019, filed 14 Aug 2019.